Reassessment of different criteria for diagnosing posthepatectomy liver failure: A single-center study of 1683 hepatectomy

Oncotarget

Volumn 8, Issue 51, 2017, Pages 89269-89277

  Zheng, Yongchang ^a   Yang, Huayu ^a   He, Li ^b   Mao, Yilei ^a   Zhang, Hanze ^c   Zhao, Haitao ^a   Du, Shunda ^a   Xu, Yiyao ^a   Chi, Tianyi ^a   Xu, Haifeng ^a   Lu, Xin ^a   Sang, Xinting ^a   Zhong, Shouxian ^a  

^a PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

"50 50" criteria; Child pugh score; Clavien Dindo; ISGLS; PHLF

Indexed keywords

HEPATITIS B ANTIGEN;

ADENOMA; ADOLESCENT; ADULT; AGED; ARTICLE; BILE DUCT CARCINOMA; CAVERNOUS HEMANGIOMA; CHILD; CHILD PUGH SCORE; CLINICAL ASSESSMENT; CONTROLLED STUDY; CRITERION VARIABLE; DISEASE CLASSIFICATION; DISEASE SEVERITY; FEMALE; FUNCTIONAL STATUS; HUMAN; INCIDENCE; LIVER CELL CARCINOMA; LIVER FAILURE; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MORBIDITY; POST HEPATECTOMY LIVER FAILURE; POSTOPERATIVE PERIOD; PROTHROMBIN TIME; RECEIVER OPERATING CHARACTERISTIC; RETROSPECTIVE STUDY; SCHOOL CHILD; SURGICAL APPROACH; SURGICAL TECHNIQUE; TUMOR VOLUME; VERY ELDERLY; YOUNG ADULT;

EID: 85031940841     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.19360     Document Type: Article

References (29)

1. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin. 2005; 55: 74-108.
2. Gandhi S, Khubchandani S, Iyer R. Quality of life and hepatocellular carcinoma. J Gastrointest Oncol. 2014; 5: 296-317.
3. El-Serag HB. Epidemiology of hepatocellular carcinoma. Clin Liver Dis. 2001; 5: 87-107, vi.
4. Goodgame B, Shaheen NJ, Galanko J, El-Serag HB. The risk of end stage liver disease and hepatocellular carcinoma among persons infected with hepatitis C virus: publication bias? Am J Gastroenterol. 2003; 98: 2535-42.
5. Llovet JM. Updated treatment approach to hepatocellular carcinoma. J Gastroenterol. 2005; 40: 225-35.
6. Cieslak KP, Bennink RJ, van Gulik TM. Prediction of postoperative liver failure in patients diagnosed with hepatocellular carcinoma using (99m)Tc-GSA SPECT/CT. Hepatobiliary Surg Nutr. 2015; 4: 203-5.
7. Pugh RN, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg. 1973; 60: 646-9.
8. Balzan S, Belghiti J, Farges O, Ogata S, Sauvanet A, Delefosse D, Durand F. The '50-50 criteria' on postoperative day 5: an accurate predictor of liver failure and death after hepatectomy. Ann Surg. 2005; 242: 824-8, discussion 8-9.
9. Wiesner R, Edwards E, Freeman R, Harper A, Kim R, Kamath P, Kremers W, Lake J, Howard T, Merion RM, Wolfe RA, Krom R, United Network for Organ Sharing Liver Disease Severity Score C. Model for end-stage liver disease (MELD) and allocation of donor livers. Gastroenterology. 2003; 124: 91-6.
10. Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004; 240: 205-13.
11. Belghiti J, Hiramatsu K, Benoist S, Massault P, Sauvanet A, Farges O. Seven hundred forty-seven hepatectomies in the 1990s: an update to evaluate the actual risk of liver resection. J Am Coll Surg. 2000; 191: 38-46.
12. Cucchetti A, Ercolani G, Vivarelli M, Cescon M, Ravaioli M, La Barba G, Zanello M, Grazi GL, Pinna AD. Impact of model for end-stage liver disease (MELD) score on prognosis after hepatectomy for hepatocellular carcinoma on cirrhosis. Liver Transpl. 2006; 12: 966-71.
13. Dinant S, de Graaf W, Verwer BJ, Bennink RJ, van Lienden KP, Gouma DJ, van Vliet AK, van Gulik TM. Risk assessment of posthepatectomy liver failure using hepatobiliary scintigraphy and CT volumetry. J Nucl Med. 2007; 48: 685-92.
14. Farges O, Malassagne B, Flejou JF, Balzan S, Sauvanet A, Belghiti J. Risk of major liver resection in patients with underlying chronic liver disease: a reappraisal. Ann Surg. 1999; 229: 210-5.
15. Karoui M, Penna C, Amin-Hashem M, Mitry E, Benoist S, Franc B, Rougier P, Nordlinger B. Influence of preoperative chemotherapy on the risk of major hepatectomy for colorectal liver metastases. Ann Surg. 2006; 243: 1-7.
16. Kawano Y, Sasaki A, Kai S, Endo Y, Iwaki K, Uchida H, Shibata K, Ohta M, Kitano S. Short-and long-term outcomes after hepatic resection for hepatocellular carcinoma with concomitant esophageal varices in patients with cirrhosis. Ann Surg Oncol. 2008; 15: 1670-6.
17. McCormack L, Petrowsky H, Jochum W, Furrer K, Clavien PA. Hepatic steatosis is a risk factor for postoperative complications after major hepatectomy: a matched case-control study. Ann Surg. 2007; 245: 923-30.
18. Rahbari NN, Garden OJ, Padbury R, Brooke-Smith M, Crawford M, Adam R, Koch M, Makuuchi M, Dematteo RP, Christophi C, Banting S, Usatoff V, Nagino M, et al. Posthepatectomy liver failure: a definition and grading by the International Study Group of Liver Surgery (ISGLS). Surgery. 2011; 149: 713-24.
19. Jarnagin WR, Gonen M, Fong Y, DeMatteo RP, Ben-Porat L, Little S, Corvera C, Weber S, Blumgart LH. Improvement in perioperative outcome after hepatic resection: analysis of 1, 803 consecutive cases over the past decade. Ann Surg. 2002; 236: 397-406; discussion-7.
20. Poon RT, Fan ST, Lo CM, Liu CL, Lam CM, Yuen WK, Yeung C, Wong J. Improving perioperative outcome expands the role of hepatectomy in management of benign and malignant hepatobiliary diseases: analysis of 1222 consecutive patients from a prospective database. Ann Surg. 2004; 240: 698-708; discussion-10.
21. Benzoni E, Lorenzin D, Baccarani U, Adani GL, Favero A, Cojutti A, Bresadola F, Uzzau A. Resective surgery for liver tumor: a multivariate analysis of causes and risk factors linked to postoperative complications. Hepatobiliary Pancreat Dis Int. 2006; 5: 526-33.
22. Paugam-Burtz C, Janny S, Delefosse D, Dahmani S, Dondero F, Mantz J, Belghiti J. Prospective validation of the 'fifty-fifty' criteria as an early and accurate predictor of death after liver resection in intensive care unit patients. Ann Surg. 2009; 249: 124-8.
23. Schroeder RA, Marroquin CE, Bute BP, Khuri S, Henderson WG, Kuo PC. Predictive indices of morbidity and mortality after liver resection. Ann Surg. 2006; 243: 373-9.
24. Stickel F, Hampe J, Trepo E, Datz C, Romeo S. PNPLA3 genetic variation in alcoholic steatosis and liver disease progression. Hepatobiliary Surg Nutr. 2015; 4: 152-60.
25. Pessaux P. Techniques and innovations in liver surgery. Hepatobiliary Surg Nutr. 2016; 5: 277-8.
26. Rahbari NN, Reissfelder C, Koch M, Elbers H, Striebel F, Buchler MW, Weitz J. The predictive value of postoperative clinical risk scores for outcome after hepatic resection: a validation analysis in 807 patients. Ann Surg Oncol. 2011; 18: 3640-9.
27. Harbrecht BG, Rosengart MR, Bukauskas K, Zenati MS, Marsh JW Jr, Geller DA. Assessment of transcutaneous bilirubinometry in hospitalized adults. J Am Coll Surg. 2008; 206: 1129-36.
28. Kimura F, Itoh H, Ambiru S, Shimizu H, Togawa A, Yoshidome H, Ohtsuka M, Shimamura F, Kato A, Nukui Y, Miyazaki M. Circulating heat-shock protein 70 is associated with postoperative infection and organ dysfunction after liver resection. Am J Surg. 2004; 187: 777-84.
29. Pessaux P, Regimbeau JM, Dondero F, Plasse M, Mantz J, Belghiti J. Randomized clinical trial evaluating the need for routine nasogastric decompression after elective hepatic resection. Br J Surg. 2007; 94: 297-303.